Publication

Causal inference with multiple concurrent medications: A comparison of methods and an application in multidrug-resistant tuberculosis

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    Arman Alam Siddique, McMaster UniversityMireille E. Schnitzer, University of MontrealAsma Bahamyirou, University of MontrealGuanbo Wang, McGill UniversityTimothy H. Holtz, Centers for Disease Control and PreventionGiovanni B. Migliori, Fondazione S. MaugeriGiovanni Sotgiu, University of SassariNeel Gandhi, Emory UniversityMario H. Vargas, Instituto Nacional de Enfermedades RespiratoriasDick Menzies, McGill UniversityAndrea Benedetti, McGill University
Language
  • English
Date
  • 2019-12-01
Publisher
  • SAGE Publications (UK and US)
Publication Version
Copyright Statement
  • © The Author(s) 2018.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0962-2802
Volume
  • 28
Issue
  • 12
Start Page
  • 3534
End Page
  • 3549
Grant/Funding Information
  • This work was supported by the Canadian Institutes of Health Research (CIHR) (project grant 378067 to MES and AB).
  • NRG is funded in part by the National Institutes of Health (NIH) (K24 award, K24AI114444).
  • MES is also funded by CIHR (New Investigators Salary Award) and the National Sciences and Engineering Council of Canada (Discovery Grant with Accelerator Supplement).
Supplemental Material (URL)
Abstract
  • This paper investigates different approaches for causal estimation under multiple concurrent medications. Our parameter of interest is the marginal mean counterfactual outcome under different combinations of medications. We explore parametric and non-parametric methods to estimate the generalized propensity score. We then apply three causal estimation approaches (inverse probability of treatment weighting, propensity score adjustment, and targeted maximum likelihood estimation) to estimate the causal parameter of interest. Focusing on the estimation of the expected outcome under the most prevalent regimens, we compare the results obtained using these methods in a simulation study with four potentially concurrent medications. We perform a second simulation study in which some combinations of medications may occur rarely or not occur at all in the dataset. Finally, we apply the methods explored to contrast the probability of patient treatment success for the most prevalent regimens of antimicrobial agents for patients with multidrug-resistant pulmonary tuberculosis.
Author Notes
  • Corresponding author: Mireille E. Schnitzer, Faculty of Pharmacy, Université de Montréal, Montreal, Québec H3C3J7, Canada. mireille.schnitzer@umontreal.ca
Keywords
Research Categories
  • Health Sciences, Public Health
  • Statistics

Tools

Relations

In Collection:

Items